Boston Scientific Korea
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Leading minimally-invasive technologies for diagnosing and treating a variety of heart and vascular conditions.
We’re committed to advancing cardiology through less invasive technologies that improve outcomes, deliver care to more patients, reduce costs, and help millions live healthier lives.
Leading minimally-invasive technologies for diagnosing and treating a variety of heart and vascular conditions.
We’re committed to advancing cardiology through less invasive technologies that improve outcomes, deliver care to more patients, reduce costs, and help millions live healthier lives.
Exhibition Item
SYNERGY XD, AGENT, WOLVERINE, ROTA PRO, OPTICROSS HD, COMET, JETSTREAM, RANGER, ACCURATE NEO 2Satellite Symposium
Lunchtime Activities
Leave the Right Agent DCB Behind: Expanding the Indications of Use
Organized by CVRF and Supported by Educational Grant from Boston Scientific Korea
Sunday, May 7
12:30 PM ~ 1:30 PM * KST (UTC/GMT +9:00)
Valve & Endovascular Theater, Vista 1, B2
Moderator(s): Bon-Kwon Koo, Hun Sik Park
Panelist(s): Jihun Ahn, Yoon Haeng Cho, Young Rak Cho, Yun-Kyeong Cho, Hyun-Hee Choi, Tae Soo Kang, Yongwhi Park
| 12:30 PM | Opening Remarks |
| 12:35 PM | Time to Move Beyond ISR - How and When Should I Consider Drug Coated Balloon (AGENT) to Treat De Novo Lesions? Lecturer: Seung Hun Lee |
| 12:50 PM | Case Presentation 1: Optimize the Vessel Preparation for a Wide Range of Lesions Treatment with DCB Lecturer: Takuma Tsuda |
| 1:05 PM | Case Presentation 2: The Importance of Optimal Lesion Preparation with IVUS for DCB Angioplasty Lecturer: Dong Oh Kang |
| 1:20 PM | Discussion |
Meet the Experts over Breakfast
Left Main & Multi-Vessel Disease Revascularization
Organized by CVRF and Supported by Educational Grant from Boston Scientific Korea
Monday, May 8
7:00 AM ~ 7:50 AM * KST (UTC/GMT +9:00)
Coronary Theater, Walker Hall, Level 1
Moderator(s): David Paul Taggart, Alan C. Yeung
Panelist(s): Francisco Jose Ayala Riquelme, Farhat Fouladvand, Katsuyuki Hasegawa, Hsien-Li Kao, Min-Kyu Kim, Ho Lam, Song Lin, Gyu-Chul Oh, Masaaki Okutsu, Aninka Saboe, Takuma Tsuda, Ping Tim Tsui, Abdul Wahab Undok
Lunchtime Activities
Drug Technology, Where We Stand?
Organized by CVRF and Supported by Educational Grant from Boston Scientific Korea
Monday, May 8
12:30 PM ~ 1:30 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Vista 3, B2
Moderator(s): In-Ho Chae, Je Hwan Won
| 12:30 PM | Eluvia : IMPERIAL Trial Lecturer: Chul-Min Ahn |
| 12:45 PM | Q&A with Panel Discussion |
| 1:00 PM | Ranger DCB: An Essential Choice for Treating Popliteal Artery Lecturer: Tae-Hoon Kim |
| 1:15 PM | Q&A and Interactive Discussion |
Lunchtime Activities
The Novel TAVI Devices in Korea : ACURATE neo2 & Sentinel
Organized by CVRF and Supported by Educational Grant from Boston Scientific Korea
Tuesday, May 9
12:30 PM ~ 1:30 PM * KST (UTC/GMT +9:00)
Coronary Theater, Walker Hall, Level 1
Moderator(s): Hyo-Soo Kim, Cheol Woong Yu
| 12:30 PM | Introduction to a New TAVI Valve - ACURATE neo2 Lecturer: Cheol Woong Yu |
| 12:45 PM | Why Should We Consider ACURATE neo2 ? - Based on Clinical Evidence Lecturer: Jeehoon Kang |
| 1:00 PM | My First Impression on using Sentinel Device during TAVI Lecturer: Si-Hyuck Kang |
| 1:15 PM | Q&A |
Training Center
Training Center
School of Rock: Conquer the Calcium
Organized by CVRF and Supported by Educational Grant from Boston Scientific Korea
Monday, May 8
2:30 PM ~ 3:30 PM * KST (UTC/GMT +9:00)
Training Center 2, Vista Hall Lobby, B2
| 2:30 PM | School of Rock: Conquer the Calcium (IVUS & ROTA Hands-on Session) |